Reduction of obesity, as induced by leptin, reverses endothelial dysfunction in obese (Lep(ob)) mice

Journal of Applied Physiology

Volumn 89, Issue 6, 2000, Pages 2382-2390

  Winters, Bradford ^a   Mo, Zhiping ^a   Brooks Asplund, Esther ^a   Kim, Soonyul ^a   Shoukas, Artin ^a   Li, Dechun ^a   Nyhan, Daniel ^a   Berkowitz, Dan E ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Diabetes; Nitric oxide

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; 4,5 DIAMINOFLUORESCEIN 2 DIACETATE; LEPTIN; LEPTIN RECEPTOR; NITRATE; NITRIC OXIDE; NITRITE; NORADRENALIN; PHENYLEPHRINE; UNCLASSIFIED DRUG;

ADIPOSE TISSUE; ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARDIOVASCULAR EFFECT; CELL DAMAGE; CONTROLLED STUDY; DIABETES MELLITUS; ENDOTHELIUM CELL; ENZYME INHIBITION; MALE; METABOLISM; MORBIDITY; MOUSE; NONHUMAN; OBESITY; PRIORITY JOURNAL; SATIETY; SIGNAL PROCESSING; VASODILATATION; WEIGHT REDUCTION;

EID: 0033672015     PISSN: 87507587     EISSN: None     Source Type: Journal    
DOI: 10.1152/jappl.2000.89.6.2382     Document Type: Article

References (45)

1. Leptin, the product of Ob gene promotes angiogenesis
2. Regulation of arterial tone by activation of calcium-dependent potassium channels
3. Effect of leptin deficiency on metabolic rate in ob/ob mice
4. The OB protein (leptin) pathway-a link between adipose tissue mass and central neural networks
5. Hyperleptinemia: An early sign of juvenile obesity. Relations to body fat depots and insulin concentrations
6. Decreased cerebrospinal-fluid/serum leptin ratio in obesity: A possible mechanism for leptin resistance
7. Serum immunoreactive-leptin concentrations in normal-weight and obese humans
8. Lipids and the endothelium
9. Sympathetic nervous system in salt-sensitive and obese hypertension: Amelioration of multiple abnormalities by a central sympatholytic agent
10. Responses of carotid artery in mice deficient in expression of the gene for endothelial NO synthase
11. Pivotal role of nitric oxide in the control of blood pressure after leptin administration
12. Endothelium-dependent hyperpolarization: A role in the control of vascular tone
13. Defective STAT signaling by the leptin receptor in diabetic mice
14. Oxidative stress and diabetic vascular complications
15. Leptin concentrations and insulin sensitivity in normoglycemic men
16. Physiological response to long-term peripheral and central leptin infusion in lean and obese mice
17. A leptin dose response study in obese (ob/ob) and lean (+/?) mice
18. Receptor-mediated regional sympathetic nerve activation by leptin
19. Cardiovascular consequences of obesity: Role of leptin
20. Sympathetic and cardiorenal actions of leptin
21. Hypertension in mice lacking the gene for endothelial nitric oxide synthase
22. Characterization of selective resistance to insulin signaling in the vasculature of obese Zucker (fa/fa) rats
23. N(G)-monomethyl L-arginine inhibits endothelium-derived relaxing factor-stimulated cyclic GMP accumulation in cocultures of endothelial and vascular smooth muscle cells by an action specific to the endothelial cell
24. Pulmonary hypertension in the obstructive sleep apnoea syndrome: Prevalence, causes and therapeutic consequences
25. Cytokine induction of NO synthase II in human DLD-1 cells: Roles of the JAK-STAT, AP-1 and NF-κB-signaling pathways
26. Abnormal splicing of the leptin receptor in diabetic mice
27. Detection and quantification of the leptin receptor splice variants Ob-Ra, b, and e in different mouse tissues
28. State-of-the-art-lecture: Obesity-induced hypertension: New concepts from the emerging biology of obesity
29. Inhibition by the JAK/STAT pathway of IFNγ- and LPS-stimulated nitric oxide synthase induction in vascular smooth muscle cells
30. Obesity and hypertension
31. Congenital leptin deficiency is associated with severe early-onset obesity in humans
32. Leptin impairs metabolic actions of insulin in isolated rat adipocytes
33. The disease burden associated with overweight and obesity
34. Effects of the obese gene product on body weight regulation in ob/ob mice
35. Nitric oxide release accounts for insulin's vascular effects in humans
36. Central nervous system control of food intake
37. Biological action of leptin as an angiogenic factor
38. Effects of leptin on insulin sensitivity in normal rats
39. Insulin-mediated skeletal muscle vasodilation is nitric oxide dependent. A novel action of insulin to increase nitric oxide release
40. Regulation of myosin phosphatase by a specific interaction with cGMP-dependent protein kinase Iα
41. Identification and expression cloning of a leptin receptor, OB-R
42. Serum leptin in subjects with impaired glucose tolerance in relation to insulin sensitivity and first-phase insulin response
43. Phenotype of the obese Koletsky (f) rat due to Tyr763Stop mutation in the extracellular domain of the leptin receptor (Lepr): Evidence for deficient plasma-to-CSF transport of leptin in both the Zucker and Koletsky obese rat
44. Insulin-stimulated production of nitric oxide is inhibited by wortmannin. Direct measurement in vascular endothelial cells
45. Positional cloning of the mouse obese gene and its human homologue